Published in World J Hepatol on January 28, 2016
Cirrhotic Cardiomyopathy: A New Clinical Phenotype. Arq Bras Cardiol (2017) 0.75
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr (2009) 14.63
The cardiac output at rest in Laennec's cirrhosis. J Clin Invest (1953) 3.94
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology (2003) 3.66
Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology (2005) 2.29
Cardiovascular complications of cirrhosis. Gut (2008) 2.06
Cardiac alterations in cirrhosis: reversibility after liver transplantation. J Hepatol (2005) 2.00
Cirrhotic cardiomyopathy. J Hepatol (2010) 1.80
Cirrhotic cardiomyopathy. J Am Coll Cardiol (2010) 1.77
Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol (2006) 1.57
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. Liver Int (2012) 1.56
Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology (1996) 1.47
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (1997) 1.41
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology (1998) 1.39
Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol (2006) 1.19
Prolongation of QTc interval: relationship with etiology and severity of liver disease, mortality and liver transplantation. Liver Int (2003) 1.17
Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol (1993) 1.15
Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol (2006) 1.08
Interactions of the heart and the liver. Eur Heart J (2013) 1.04
Cirrhotic cardiomyopathy. Orphanet J Rare Dis (2007) 1.03
Acute non-selective beta-adrenergic blockade reduces prolonged frequency-adjusted Q-T interval (QTc) in patients with cirrhosis. J Hepatol (2004) 1.03
New insights into cirrhotic cardiomyopathy. Int J Cardiol (2012) 1.02
Cardiac dysfunction in cirrhosis. Best Pract Res Clin Gastroenterol (2007) 1.02
Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging. Liver Int (2011) 0.96
Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease. Eur J Intern Med (2012) 0.95
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol (2003) 0.92
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. J Hepatol (2007) 0.92
Cirrhotic cardiomyopathy. Ann Hepatol (2006) 0.88
Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. Eur J Heart Fail (2011) 0.86
Cardiac dysfunction in spontaneous bacterial peritonitis: a manifestation of cirrhotic cardiomyopathy? Hepatology (2003) 0.85
The cardiorenal link in advanced cirrhosis. Med Hypotheses (2012) 0.84
Cirrhotic cardiomyopathy. World J Gastroenterol (2015) 0.84
Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis. Transpl Int (2012) 0.83
Effect of cirrhosis and liver transplantation on the gender difference in QT interval. Am J Cardiol (2005) 0.83
Cirrhotic cardiomyopathy and hepatopulmonary syndrome: prevalence and prognosis in a series of patients. Respir Med (2013) 0.82
What happens to cirrhotic cardiomyopathy after liver transplantation? Hepatology (2005) 0.81
Prolongation of the QTc-interval reflects the severity of autonomic neuropathy in primary biliary cirrhosis and in other non-alcoholic liver diseases. Z Gastroenterol (1993) 0.80
Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia. Dig Dis Sci (2013) 0.80